4//SEC Filing
BLATT LAWRENCE 4
Accession 0001610717-25-000290
CIK 0001799448other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 5:14 PM ET
Size
5.3 KB
Accession
0001610717-25-000290
Insider Transaction Report
Form 4
BLATT LAWRENCE
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-07-16+179,800→ 179,800 totalExercise: $8.68Exp: 2035-07-16→ Common Stock (179,800 underlying)
Footnotes (1)
- [F1]1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from July 16, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Aligos Therapeutics, Inc.
CIK 0001799448
Entity typeother
Related Parties
1- filerCIK 0001242110
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 5:14 PM ET
- Size
- 5.3 KB